Results 81 to 90 of about 34,070 (177)

Radiopharmaceutical transport in solid tumors via a 3-dimensional image-based spatiotemporal model

open access: yesnpj Systems Biology and Applications
Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA)-targeted radiopharmaceutical therapy is a clinically approved treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
Anahita Piranfar   +6 more
doaj   +1 more source

Radiopharmacologist’s and Radiochemist’s View on Targeting the Eph/Ephrin Receptor Tyrosine Kinase System

open access: yesACS Omega, 2020
Christin Neuber   +3 more
doaj   +1 more source

Targeting Cancer Stem Cells with Radioimmunotherapy: The Case of the Ovarian Cancer Stemness-Associated Biomarker L1CAM

open access: yesInternational Journal of Translational Medicine
Cancer stem cells (CSCs) are a dynamic population of tumor cells characterized by long-term self-renewal, high tumorigenicity, resistance to conventional therapies such as radio- and chemotherapy, and capacity to recapitulate the tumor heterogeneity ...
Tihomir Zh. Todorov   +3 more
doaj   +1 more source

Studies on ToF-PET using Cherenkov radiation [PDF]

open access: yes, 2015
La tomografia ad emissione di positroni (PET) è una tecnica di imaging di medicina nucleare, utilizzata oggi diffusamente in ambito clinico. Essa fornisce immagini e informazioni fisiologiche dei processi funzionali all’interno del corpo.
La Rosa, Francesco
core  

Hydrogel-Based Strategies for the Prevention and Treatment of Radiation-Induced Skin Injury: Progress and Mechanistic Insights

open access: yesBiomimetics
Radiation-induced skin injury (RISI) is one of the most common complications of radiotherapy, severely compromising patients’ quality of life. However, no standardized treatment has yet been established.
Yinhui Wang   +7 more
doaj   +1 more source

Targeting the BB2 receptor on human prostate cancer cells using Indium-111 labeled radiopharmaceutical [abstract] [PDF]

open access: yes, 2006
only availableFaculty Mentor: Dr. Timothy Hoffman, Internal MedicineThe BB2 receptor, belonging to the Bombesin receptor family, has been shown to be highly over expressed in a variety of cancer cell lines, including human prostate cancer.
Bell, N. R.   +8 more
core  

Optimized production of 89Zr as a medical radioisotope on a variable energy cyclotron and external beam-line

open access: yesEJNMMI Physics
Background Zirconium-89 (89Zr) is a highly valued diagnostic radionuclide for positron emission tomography (PET) due to its long physical half-life of 78.4 h and decay characteristics, being preferred for the radiolabelling of nanoparticles and slow ...
Diana Cocioabă   +7 more
doaj   +1 more source

Radiopharmaceuticals [PDF]

open access: yesActa Radiologica. Diagnosis, 1966
openaire   +2 more sources

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

open access: yesEJNMMI Radiopharmacy and Chemistry
Background Programmed cell death ligand 1 (PD-L1) plays a critical role in the tumor microenvironment and overexpression in several solid cancers has been reported. This was associated with a downregulation of the local immune response, specifically of T-
Fabian Krutzek   +2 more
doaj   +1 more source

In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency

open access: yesPharmaceuticals
Background/Objectives: The cell surface proteoglycan glypican-3 (GPC3) is reportedly overexpressed in hepatocellular carcinoma (HCC) tissues, but not in benign liver tissues, rendering this protein a potential target for radionuclide theranostic ...
Eva-Maria Burger   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy